BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25275295)

  • 21. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
    Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
    Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
    Greenbaum A; Martin DR; Bocklage T; Lee JH; Ness SA; Rajput A
    Clin Colorectal Cancer; 2019 Jun; 18(2):102-109. PubMed ID: 30935775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.
    Kamran SC; Lennerz JK; Margolis CA; Liu D; Reardon B; Wankowicz SA; Van Seventer EE; Tracy A; Wo JY; Carter SL; Willers H; Corcoran RB; Hong TS; Van Allen EM
    Clin Cancer Res; 2019 Sep; 25(18):5561-5571. PubMed ID: 31253631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer.
    Esposito G; Pucciarelli S; Alaggio R; Giacomelli L; Marchiori E; Iaderosa GA; Friso ML; Toppan P; Chieco-Bianchi L; Lise M
    Ann Surg Oncol; 2001 May; 8(4):311-8. PubMed ID: 11352304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy.
    Yang J; Lin Y; Huang Y; Jin J; Zou S; Zhang X; Li H; Feng T; Chen J; Zuo Z; Zheng J; Li Y; Gao G; Wu C; Tan W; Lin D
    Theranostics; 2019; 9(23):6856-6866. PubMed ID: 31660073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
    Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Case of Locally Advanced Rectal Cancer with a Pathological Complete Response to Preoperative Chemoradiotherapy].
    Akahoshi S; Iizaka M; Murakami S; Nimura S; Takeguchi T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2316-8. PubMed ID: 26805349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
    Yang KL; Yang SH; Liang WY; Kuo YJ; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Chu LS; Wang LW
    Radiat Oncol; 2013 Mar; 8():43. PubMed ID: 23452434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
    Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preoperative chemoradiotherapy for resectable lower rectal cancer].
    Takase S; Kamigaki T; Yamashita K; Nakamura T; Nishimura H; Sasaki R
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2006-8. PubMed ID: 20037306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.
    Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Fukayama M; Watanabe T
    Dis Colon Rectum; 2017 Apr; 60(4):368-375. PubMed ID: 28267003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
    Jakob C; Liersch T; Meyer W; Becker H; Baretton GB; Aust DE
    World J Gastroenterol; 2008 Feb; 14(7):1060-6. PubMed ID: 18286688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
    Kao PS; Chang SC; Wang LW; Lee RC; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK
    J Surg Oncol; 2010 Dec; 102(7):771-7. PubMed ID: 20872811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis.
    Huh JW; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim HC; Park HC; Choi DH; Park JO; Park YS; Chun HK
    Yonsei Med J; 2015 Jan; 56(1):82-8. PubMed ID: 25510750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
    Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
    Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Yoon G; Park JY; Kim HJ; Choi GS; Kim JG; Kang BW; Kang MK; Seo AN
    Anticancer Res; 2019 Jun; 39(6):2845-2853. PubMed ID: 31177122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preoperative chemoradiotherapy for rectal cancer: experience from one centre].
    Lescut N; Lepinoy A; Schipman B; Cerda T; Guimas V; Bednarek C; Bosset JF
    Cancer Radiother; 2015 Apr; 19(2):98-105. PubMed ID: 25769650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLUT-1 expression and response to chemoradiotherapy in rectal cancer.
    Brophy S; Sheehan KM; McNamara DA; Deasy J; Bouchier-Hayes DJ; Kay EW
    Int J Cancer; 2009 Dec; 125(12):2778-82. PubMed ID: 19569052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.